Blood Biomarkers of Neuronal Injury and Astrocytic Reactivity in ECT: New Study From Sweden
Out on PubMed,from investigators mostly in Sweden, is this study: Blood biomarkers of neuronal injury and astrocytic reactivity in electroconvulsive therapy. Sigström R, Göteson A, Joas E, Pålsson E, Liberg B, Nordenskjöld A, Blennow K, Zetterberg H, Landén M. Mol Psychiatry. 2024 Oct 3. doi: 10.1038/s41380-024-02774-4. Online ahead of print. PMID: 39363047 The abstract is copied below: Despite electroconvulsive therapy (ECT) being recognized as an effective treatment for major depressive episodes (MDE), its application is subject to controversy due to concerns over cognitive side effects. The pathophysiology of these side effects is not well understood. Here, we examined the effects of ECT on blood-based biomarkers of neuronal injury and astrocytic reactivity. Participants with a major depressive episode (N = 99) underwent acute ECT. Blood was sampled just before (T0) and 30 min after (T1) the first ECT session, as well as just before the sixth session (T2; 48-72 h after the fifth s